Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality

BACKGROUND: The societal, clinical and economic burden imposed by the complications of chronic hepatitis C virus (HCV) infection - including cirrhosis and hepatocellular carcinoma (HCC) - is expected to increase over the coming decades. However, new therapies may improve sustained virological respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Cramp, Matthew E, Rosenberg, William M, Ryder, Steven D, Blach, Sarah, Parkes, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128826/
https://www.ncbi.nlm.nih.gov/pubmed/25100159
http://dx.doi.org/10.1186/1471-230X-14-137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128826/
https://www.ncbi.nlm.nih.gov/pubmed/25100159
http://dx.doi.org/10.1186/1471-230X-14-137

Ejemplares similares